BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 17496757)

  • 41. The use of surfactants in 2009.
    Sweet DG; Halliday HL
    Arch Dis Child Educ Pract Ed; 2009 Jun; 94(3):78-83. PubMed ID: 19460896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect from surfactant therapy in extremely low birth weight infants depending on the method of delivery].
    Iarŭkova N; Nikolov A; Slŭncheva B; Vakrilova L; Pramatarova T; Dimitrov A
    Akush Ginekol (Sofiia); 2007; 46(3):31-5. PubMed ID: 18018780
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
    Teksam O; Kale G
    Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary surfactant: physiology, pharmacology and clinical uses.
    Morton NS
    Br J Hosp Med; 1989 Jul; 42(1):52-8. PubMed ID: 2673470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surfactant-replacement therapy for respiratory distress syndrome in the preterm and term neonate: congratulations and corrections.
    Moya F; Sinha S; D'Agostino RB
    Pediatrics; 2008 Jun; 121(6):1290-1; author reply 1291-2. PubMed ID: 18519504
    [No Abstract]   [Full Text] [Related]  

  • 46. To tube or not to tube babies with respiratory distress syndrome.
    Sekar KC; Corff KE
    J Perinatol; 2009 May; 29 Suppl 2():S68-72. PubMed ID: 19399013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of neonatal respiratory distress syndrome with surfactant BL].
    Zatovka GN; Duginova SA; Safarov AA; Nechaeva MV; Blauberg EN
    Anesteziol Reanimatol; 2006; (1):38-43. PubMed ID: 16613043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
    Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimal ventilatory strategies and surfactant to protect the preterm lungs.
    Ramanathan R
    Neonatology; 2008; 93(4):302-8. PubMed ID: 18525214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Surfactant replacement therapy in neonatal respiratory distress syndrome: prophylactic therapy versus treating of established disease].
    Lubetzky R; Dolberg S
    Harefuah; 1999 Nov; 137(10):464-7. PubMed ID: 10959346
    [No Abstract]   [Full Text] [Related]  

  • 51. Defects in surfactant synthesis: clinical implications.
    Cole FS; Nogee LM; Hamvas A
    Pediatr Clin North Am; 2006 Oct; 53(5):911-27, ix. PubMed ID: 17027617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myth: all surfactants are alike.
    Moya F; Javier MC
    Semin Fetal Neonatal Med; 2011 Oct; 16(5):269-74. PubMed ID: 21515101
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bubble continuous positive airway pressure, a potentially better practice, reduces the use of mechanical ventilation among very low birth weight infants with respiratory distress syndrome.
    Nowadzky T; Pantoja A; Britton JR
    Pediatrics; 2009 Jun; 123(6):1534-40. PubMed ID: 19482765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nasopharyngeal surfactant administration to prevent neonatal respiratory distress syndrome.
    Fernandes CJ; Horst DA; O'Donovan DJ
    J Perinatol; 2005 May; 25(5):361-2; author reply 363. PubMed ID: 15861205
    [No Abstract]   [Full Text] [Related]  

  • 55. Animal-derived surfactant treatment of respiratory distress syndrome in premature neonates: a review.
    Fujii AM; Carillo M
    Drugs Today (Barc); 2009 Sep; 45(9):697-709. PubMed ID: 19956811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lung surfactant in an era of replacement therapy.
    Notter RH; Shapiro DL
    Pediatrics; 1981 Dec; 68(6):781-9. PubMed ID: 6275335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Other indications for surfactant].
    Proença Fernandes E; Carvalho C; Silva A; Ferreira P; Alegria A; Lopes L; Areias MA
    An Esp Pediatr; 2002 Jan; 56(1):45-8. PubMed ID: 11792244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes.
    Carnielli VP; Zimmermann LJ; Hamvas A; Cogo PE
    J Perinatol; 2009 May; 29 Suppl 2():S29-37. PubMed ID: 19399007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surfactant therapy in neonatal respiratory distress syndrome.
    Nagesh K; Bhat V; Kunikullaya S; Rajesh N
    Indian Pediatr; 1994 Aug; 31(8):971-7. PubMed ID: 7883350
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of surfactant for respiratory distress syndrome.
    Mallamo K
    Neonatal Netw; 1999 Oct; 18(7):43. PubMed ID: 10808888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.